Phathom Pharmaceuticals (NASDAQ:PHAT) Stock Price Expected to Rise, Craig Hallum Analyst Says
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) had its price target hoisted by equities researchers at Craig Hallum from $12.00 to $17.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price objective indicates a potential upside of 89.52% from the company’s current price. […]
Phathom Pharmaceuticals (NASDAQ:PHAT – Get Free Report) had its price target hoisted by equities researchers at Craig Hallum from $12.00 to $17.00 in a research report issued on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. Craig Hallum’s price objective indicates a potential upside of 89.52% from the company’s current price. […]
